Amino Acids as biomarkers in the SOD1G93A mouse model of ALS
Authors:
- Robert E. GrierRGRobert E. Grier
- Richard NeedlemanRNRichard Needleman
- William S.A. BrusilowWBWilliam S.A. Brusilow
- 1 January 2014
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1842 (1) , 79-87
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- The genetics and neuropathology of amyotrophic lateral sclerosisActa Neuropathologica, 2012
- Biomarkers in Amyotrophic Lateral SclerosisMolecular Diagnosis & Therapy, 2009
- Biomarkers in amyotrophic lateral sclerosisThe Lancet Neurology, 2009
- Amyotrophic lateral sclerosis: recent advances and future therapiesCurrent Opinion in Neurology, 2005
- Skeletal Muscle in Amyotrophic Lateral Sclerosis: Emerging Concepts and Therapeutic ImplicationsPhysical Medicine and Rehabilitation Clinics of North America, 2005
- Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysisActa Neurologica Scandinavica, 1993
- Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluidAnnals of Neurology, 1990
- Hepatic Ultrastructural Changes and Liver Dysfunction in Amyotrophic Lateral SclerosisArchives of Neurology, 1987
- [27] Glutamine synthetase from mammalian tissues1985
- A rapid colorimetric assay for carbamyl phosphate synthetase IJournal of Biochemical and Biophysical Methods, 1980